Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001493152-25-021898·Megiddo Dalia
Schedule 13G ownership disclosure
NASUS PHARMA LTD
Ordinary Shares · CUSIP: M7071P109
Event date: 2025-09-30
- Filing-level shares
- 1,888,873.00
- Percent of class
- 20.9%
- Dr. Dalia Megiddo
Shares: 1,888,873.00 · Class: 20.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-021898
- Form type
- SCHEDULE 13G
- Filer
- Megiddo Dalia
- CIK
- CIK 1599618
- Filed
- Nov 12, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership